المؤلفون: Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M.I. Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Shruti Srivastava, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M. Broome

المصدر: EClinicalMedicine, Vol 74, Iss , Pp 102733- (2024)

مصطلحات موضوعية: Autoimmune haemolytic anaemia, Cold agglutinin disease, Classical complement pathway, Complement C1s, Sutimlimab, Haemolysis, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2589537024003122; https://doaj.org/toc/2589-5370

URL الوصول: https://doaj.org/article/3d87b23487004a108e8a911cd7c2cb67

المؤلفون: Hiroki Kobayashi, Hiromasa Takeda, Shoji Asakura, Tadashi Yoshino, Tomofumi Yano, Tomoki Ouchi, Wataru Kitamura, Yoshinobu Maeda, Yoshiyuki Tokuda

المصدر: Journal of Clinical and Experimental Hematopathology. 2023, 63(4):246

المؤلفون: Kobayashi, Hiroki, Ouchi, Tomoki, Kitamura, Wataru, Asakura, Shoji, Yano, Tomofumi, Takeda, Hiromasa, Tokuda, Yoshiyuki, Yoshino, Tadashi, Maeda, Yoshinobu

المصدر: Journal of Clinical and Experimental Hematopathology

مصطلحات موضوعية: cold agglutinin disease, severe acute respiratory syndrome coronavirus 2, sutimlimab

Relation: info:pmid/38148014; https://ousar.lib.okayama-u.ac.jp/files/public/6/66532/20240124151343867367/fulltext.pdf; AA11556796; https://ousar.lib.okayama-u.ac.jp/66532

الاتاحة: https://ousar.lib.okayama-u.ac.jp/files/public/6/66532/20240124151343867367/fulltext.pdf
https://ousar.lib.okayama-u.ac.jp/66532

المؤلفون: 新薬紹介委員会

المصدر: ファルマシア / Farumashia. 2022, 58(11):1069

المؤلفون: García-Luque,A, Silva-Cuevas,MA, Granda-Lobato,P, Correa-Pérez,A

المصدر: Sanidad Militar v.78 n.4 2022

مصطلحات موضوعية: Abaloparatida (Eladynos®), Espesolimab (Spevigo®), Faricimab (Vabysmo®), Fosdenopterina (Nulibry®), Gozetotida (Locametz®), Loncastuximab tesirina (Zynlonta®), Maralixibat (Livmarli®), Maribavir (Livtencity®), Mitapivat (Pyrukynd®), Nirsevibab (Beyforuts®), Nivolumab/Relatlimab (Opdualag®), Sutimlimab (Enjaymo®), Tabelecleucel (Ebvallo®), Teclistamab (Tecvayli®), Tezepelumab (Tezspire®), Tirzepatida (Mounjaro®), Vacuna tetravalente contra el dengue (Qdenga®), Vipivotida tetraxetan lutecio (177LU) (Pluvicto®), Voclosporina (Lupkynis®), Vutrisiran (Amvuttra®)

وصف الملف: text/html

الاتاحة: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1887-85712022000400010

المؤلفون: David J. Kuter, Hanny Al-Samkari, Abraham Z. Cheloff

المصدر: Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 5, Pp 807-812 (2020)

مصطلحات موضوعية: medicine.medical_specialty, Thrombopoietin Receptor Agonists, Treatment response, blood platelets, Platelet disorder, Immunology, Disease, thrombocytopenic, Complement Hemolytic Activity Assay, Gastroenterology, Biochemistry, immune system diseases, hemic and lymphatic diseases, Internal medicine, Original Articles: Hemostasis, medicine, Platelet, sutimlimab, biology, lcsh:RC633-647.5, business.industry, Brief Report, complement C4, lcsh:Diseases of the blood and blood-forming organs, complement C3, Odds ratio, Cell Biology, Hematology, Confidence interval, Immune thrombocytopenia, C1 esterase, immune thrombocytopenia, purpura, complement hemolytic activity assay, biology.protein, idiopathic, Patient evaluation, Antibody, business, Low Complement, Serum complement

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe13d10dc9706419942c3952534dc91
https://doi.org/10.1182/blood-2019-125341